Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30379% above fair value
$15.71−0.15 (-0.95%)
Close on Nov 13, 2026Market cap $1.68BP/E –Yield –
Personalis total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Personalis's total debt was $20.06M at Jun 30, 2019. For fiscal 2018 it was $9.99M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $9.99M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2019 | Jun 30, 2019 | $20.06M | – |
| Q4 FY2018 | Dec 31, 2018 | $9.99M | – |
See a number that looks wrong?